These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15659501)

  • 1. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse.
    Huang HY; Illei PB; Zhao Z; Mazumdar M; Huvos AG; Healey JH; Wexler LH; Gorlick R; Meyers P; Ladanyi M
    J Clin Oncol; 2005 Jan; 23(3):548-58. PubMed ID: 15659501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of P53 status in Ewing sarcoma.
    de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
    Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
    Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
    Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
    Wang H; Zheng J; Wang YP; Yang Y; You JF
    Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of fusion subtype in Ewing sarcoma.
    Barr FG; Meyer WH
    J Clin Oncol; 2010 Apr; 28(12):1973-4. PubMed ID: 20308653
    [No Abstract]   [Full Text] [Related]  

  • 10. The EWS protein is dispensable for Ewing tumor growth.
    Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
    Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
    Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
    Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E1A and the Ewing tumor translocation.
    Kovar H
    Nat Med; 1999 Dec; 5(12):1331. PubMed ID: 10581050
    [No Abstract]   [Full Text] [Related]  

  • 14. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.
    Sanchez-Prieto R; de Alava E; Palomino T; Guinea J; Fernandez V; Cebrian S; LLeonart M; Cabello P; Martin P; San Roman C; Bornstein R; Pardo J; Martinez A; Diaz-Espada F; Barrios Y; Ramon y Cajal S
    Nat Med; 1999 Sep; 5(9):1076-9. PubMed ID: 10470089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrangement of chromosome 11 and 22 territories, EWSR1 and FLI1 genes, and other genetic elements of these chromosomes in human lymphocytes and Ewing sarcoma cells.
    Taslerová R; Kozubek S; Lukásová E; Jirsová P; Bártová E; Kozubek M
    Hum Genet; 2003 Feb; 112(2):143-55. PubMed ID: 12522555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous Ewing sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis.
    Shingde MV; Buckland M; Busam KJ; McCarthy SW; Wilmott J; Thompson JF; Scolyer RA
    J Clin Pathol; 2009 Oct; 62(10):915-9. PubMed ID: 19783720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
    Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
    Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.